Valeant is at it again with another aquisition. This time it will buy Janssen's Ortho dermatologics business for $345 million in cash. The business had sales of $150 million in 2010. It includes the brands Retin-A-Micro, Ertaczo, and Renova.
Valeant has now added two dermatology groups within a week with its previous acquisition of Sanofi's Dermik unit for $425 million. "With the combination of this transaction and other recently announced transactions, Valeant is well on its way to being one of the leading companies in dermatology," states J. Michael Pearson, Valeant's CEO and chairman.
Posted by Bruce Lehr July 15th 2011.